$Merck(MRK.US) rose more than three points, $Eli Lilly(LLY.US), and $Health Care Select Sector SPDR(XLV.US) also rose two to three points. Both large pharma and broad-based healthcare sectors are strengthening together. In a low-volatility environment, capital is flowing into defensive and steady-growth sectors like healthcare. Large pharmaceutical companies can rise without needing specific catalysts, and the long-term logic of $Eli Lilly(LLY.US)'s weight-loss drug is still providing support. Holding healthcare leaders at times like this is for stability; they may not rise quickly, but it gives peace of mind 😎